

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 9.45062929 |
| 2 | cardiac myofibril assembly (GO:0055003) | 8.73734684 |
| 3 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 8.06855090 |
| 4 | myofibril assembly (GO:0030239) | 7.92002125 |
| 5 | actin-myosin filament sliding (GO:0033275) | 7.58159207 |
| 6 | muscle filament sliding (GO:0030049) | 7.58159207 |
| 7 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 7.34034214 |
| 8 | cardiac muscle contraction (GO:0060048) | 6.77926148 |
| 9 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.69424867 |
| 10 | plasma membrane repair (GO:0001778) | 6.67478721 |
| 11 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.51015566 |
| 12 | cardiac muscle cell development (GO:0055013) | 6.42977663 |
| 13 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.33994935 |
| 14 | actin-mediated cell contraction (GO:0070252) | 6.26952222 |
| 15 | regulation of actin filament-based movement (GO:1903115) | 6.15930511 |
| 16 | tricarboxylic acid cycle (GO:0006099) | 6.15314148 |
| 17 | regulation of skeletal muscle contraction (GO:0014819) | 6.04808924 |
| 18 | cardiac cell development (GO:0055006) | 6.04166582 |
| 19 | actomyosin structure organization (GO:0031032) | 5.94647522 |
| 20 | adult heart development (GO:0007512) | 5.84045283 |
| 21 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.83550677 |
| 22 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.77855421 |
| 23 | regulation of relaxation of muscle (GO:1901077) | 5.76837592 |
| 24 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.73493142 |
| 25 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.72492305 |
| 26 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.71520805 |
| 27 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 5.66290194 |
| 28 | cardiac muscle hypertrophy (GO:0003300) | 5.49781799 |
| 29 | striated muscle contraction (GO:0006941) | 5.49069924 |
| 30 | striated muscle hypertrophy (GO:0014897) | 5.23128759 |
| 31 | regulation of sarcomere organization (GO:0060297) | 5.23063985 |
| 32 | muscle tissue morphogenesis (GO:0060415) | 5.22209861 |
| 33 | heart trabecula formation (GO:0060347) | 5.20726938 |
| 34 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.17572199 |
| 35 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.16589713 |
| 36 | carnitine shuttle (GO:0006853) | 5.12907141 |
| 37 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.01288593 |
| 38 | regulation of striated muscle contraction (GO:0006942) | 4.99790205 |
| 39 | cardiac chamber formation (GO:0003207) | 4.97248808 |
| 40 | heart contraction (GO:0060047) | 4.89476328 |
| 41 | heart process (GO:0003015) | 4.89476328 |
| 42 | regulation of cell communication by electrical coupling (GO:0010649) | 4.89161986 |
| 43 | regulation of the force of heart contraction (GO:0002026) | 4.75798679 |
| 44 | actin filament-based movement (GO:0030048) | 4.72681386 |
| 45 | regulation of membrane repolarization (GO:0060306) | 4.72624314 |
| 46 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.69586936 |
| 47 | muscle hypertrophy (GO:0014896) | 4.63103347 |
| 48 | cell communication involved in cardiac conduction (GO:0086065) | 4.62800559 |
| 49 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.60967401 |
| 50 | cardiac ventricle formation (GO:0003211) | 4.52759427 |
| 51 | fatty acid transmembrane transport (GO:1902001) | 4.40663604 |
| 52 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.38719392 |
| 53 | regulation of coenzyme metabolic process (GO:0051196) | 4.27885645 |
| 54 | regulation of cofactor metabolic process (GO:0051193) | 4.27885645 |
| 55 | regulation of cardioblast differentiation (GO:0051890) | 4.24874033 |
| 56 | regulation of cardiac muscle cell contraction (GO:0086004) | 4.23009300 |
| 57 | regulation of cardiac muscle contraction (GO:0055117) | 4.14311861 |
| 58 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 4.12155778 |
| 59 | negative regulation of protein localization to cell surface (GO:2000009) | 4.08529338 |
| 60 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 4.06247444 |
| 61 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 4.03080744 |
| 62 | muscle hypertrophy in response to stress (GO:0003299) | 4.03080744 |
| 63 | cardiac muscle adaptation (GO:0014887) | 4.03080744 |
| 64 | negative regulation of potassium ion transport (GO:0043267) | 4.02332608 |
| 65 | cardiac muscle cell action potential (GO:0086001) | 4.01791081 |
| 66 | regulation of heart rate (GO:0002027) | 4.00766887 |
| 67 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.99829719 |
| 68 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.96555966 |
| 69 | cell communication by electrical coupling (GO:0010644) | 3.96293493 |
| 70 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.91936393 |
| 71 | creatine metabolic process (GO:0006600) | 3.88842176 |
| 72 | regulation of ATPase activity (GO:0043462) | 3.85952558 |
| 73 | regulation of ATP catabolic process (GO:1903289) | 3.85952558 |
| 74 | skeletal muscle contraction (GO:0003009) | 3.80090526 |
| 75 | carnitine transmembrane transport (GO:1902603) | 3.79385255 |
| 76 | NADH metabolic process (GO:0006734) | 3.77433975 |
| 77 | regulation of muscle contraction (GO:0006937) | 3.75021350 |
| 78 | 2-oxoglutarate metabolic process (GO:0006103) | 3.73351423 |
| 79 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.73242090 |
| 80 | striated muscle cell development (GO:0055002) | 3.72892596 |
| 81 | oxygen transport (GO:0015671) | 3.72244959 |
| 82 | muscle contraction (GO:0006936) | 3.70293837 |
| 83 | relaxation of cardiac muscle (GO:0055119) | 3.70053703 |
| 84 | cellular response to epinephrine stimulus (GO:0071872) | 3.68691135 |
| 85 | ATP synthesis coupled proton transport (GO:0015986) | 3.67327118 |
| 86 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.67327118 |
| 87 | * regulation of heart contraction (GO:0008016) | 3.62896786 |
| 88 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.62530988 |
| 89 | response to epinephrine (GO:0071871) | 3.61681813 |
| 90 | response to muscle activity (GO:0014850) | 3.57844830 |
| 91 | ventricular cardiac muscle cell development (GO:0055015) | 3.56765154 |
| 92 | respiratory electron transport chain (GO:0022904) | 3.54459791 |
| 93 | detection of calcium ion (GO:0005513) | 3.54175118 |
| 94 | cardiac conduction (GO:0061337) | 3.53824285 |
| 95 | oxidative phosphorylation (GO:0006119) | 3.51475706 |
| 96 | atrial septum morphogenesis (GO:0060413) | 3.51324810 |
| 97 | regulation of sulfur metabolic process (GO:0042762) | 3.50626617 |
| 98 | regulation of muscle system process (GO:0090257) | 3.50334413 |
| 99 | positive regulation of cation channel activity (GO:2001259) | 3.49819659 |
| 100 | response to inactivity (GO:0014854) | 3.49201869 |
| 101 | muscle system process (GO:0003012) | 3.46582487 |
| 102 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.46231925 |
| 103 | amino-acid betaine transport (GO:0015838) | 3.44806211 |
| 104 | carnitine transport (GO:0015879) | 3.44806211 |
| 105 | regulation of sequestering of triglyceride (GO:0010889) | 3.43765200 |
| 106 | electron transport chain (GO:0022900) | 3.43362618 |
| 107 | striated muscle adaptation (GO:0014888) | 3.42959588 |
| 108 | positive regulation of heart contraction (GO:0045823) | 3.40523040 |
| 109 | positive regulation of heart rate (GO:0010460) | 3.39795376 |
| 110 | cardiac muscle tissue development (GO:0048738) | 3.39630581 |
| 111 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.38387971 |
| 112 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.38387971 |
| 113 | muscle cell development (GO:0055001) | 3.30490385 |
| 114 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.26729668 |
| 115 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.26729668 |
| 116 | adrenergic receptor signaling pathway (GO:0071875) | 3.24119346 |
| 117 | muscle fiber development (GO:0048747) | 3.22158441 |
| 118 | relaxation of muscle (GO:0090075) | 3.17812504 |
| 119 | response to caffeine (GO:0031000) | 3.11841816 |
| 120 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.11014552 |
| 121 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.07758556 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.37788782 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 4.96556798 |
| 3 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 4.13445992 |
| 4 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 4.13445992 |
| 5 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.08983009 |
| 6 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.70782420 |
| 7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.69217318 |
| 8 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 3.19543033 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.17979221 |
| 10 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.08692830 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.87402958 |
| 12 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.60372087 |
| 13 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.28180501 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.25056006 |
| 15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.22034906 |
| 16 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.16118250 |
| 17 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.12798144 |
| 18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.98929630 |
| 19 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.96710407 |
| 20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.87482690 |
| 21 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.82435093 |
| 22 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.80880012 |
| 23 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.76361875 |
| 24 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.75122541 |
| 25 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.74097507 |
| 26 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.73197901 |
| 27 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.54361440 |
| 28 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.54286550 |
| 29 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.51185668 |
| 30 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.46603879 |
| 31 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.46532550 |
| 32 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.42909090 |
| 33 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.39785660 |
| 34 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.33694827 |
| 35 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.32871976 |
| 36 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.32662093 |
| 37 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.32662093 |
| 38 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.31804200 |
| 39 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.30775735 |
| 40 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.29981629 |
| 41 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.28680371 |
| 42 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.28403285 |
| 43 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.28071506 |
| 44 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.27105109 |
| 45 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26175899 |
| 46 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.25214772 |
| 47 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.23297043 |
| 48 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.23156651 |
| 49 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.23075771 |
| 50 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.23048862 |
| 51 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.21977123 |
| 52 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.21576156 |
| 53 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.21319511 |
| 54 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.20351574 |
| 55 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.19746919 |
| 56 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.17730246 |
| 57 | GATA1_19941826_ChIP-Seq_K562_Human | 1.16840190 |
| 58 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.15273556 |
| 59 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.13504542 |
| 60 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.08696330 |
| 61 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.07460231 |
| 62 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.07406482 |
| 63 | ATF3_27146783_Chip-Seq_COLON_Human | 1.06900222 |
| 64 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05670496 |
| 65 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.05211095 |
| 66 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.05050031 |
| 67 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03418380 |
| 68 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.02433421 |
| 69 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.01960003 |
| 70 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99871102 |
| 71 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.99386940 |
| 72 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.99079388 |
| 73 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.98549789 |
| 74 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.98301872 |
| 75 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.98033465 |
| 76 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.97385116 |
| 77 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.96766389 |
| 78 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.96721346 |
| 79 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.96284059 |
| 80 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.94361143 |
| 81 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.92435309 |
| 82 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.92365379 |
| 83 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.90320621 |
| 84 | * P68_20966046_ChIP-Seq_HELA_Human | 0.90242062 |
| 85 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.89671978 |
| 86 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.89660961 |
| 87 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.89660961 |
| 88 | GATA2_19941826_ChIP-Seq_K562_Human | 0.89235187 |
| 89 | CJUN_26792858_Chip-Seq_BT549_Human | 0.88878878 |
| 90 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.88255641 |
| 91 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.88169594 |
| 92 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.87701751 |
| 93 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.87498956 |
| 94 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.87467232 |
| 95 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.87334427 |
| 96 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.86996995 |
| 97 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.86881315 |
| 98 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.86832150 |
| 99 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.86240903 |
| 100 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.85118886 |
| 101 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.84900327 |
| 102 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.84589312 |
| 103 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84350897 |
| 104 | SPI1_23127762_ChIP-Seq_K562_Human | 0.83936382 |
| 105 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.83433681 |
| 106 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.82991269 |
| 107 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.82794810 |
| 108 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.81733390 |
| 109 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.81577640 |
| 110 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.81456157 |
| 111 | KDM2B_26808549_Chip-Seq_K562_Human | 0.81385852 |
| 112 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.80561174 |
| 113 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.79657214 |
| 114 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.78431712 |
| 115 | GATA1_22025678_ChIP-Seq_K562_Human | 0.77627007 |
| 116 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.77469831 |
| 117 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.77250635 |
| 118 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.77229539 |
| 119 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.77149168 |
| 120 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.77118149 |
| 121 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.76518260 |
| 122 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.76245729 |
| 123 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.76017448 |
| 124 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.75779704 |
| 125 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.75760098 |
| 126 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75737296 |
| 127 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.75304654 |
| 128 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.73796150 |
| 129 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.73500787 |
| 130 | VDR_22108803_ChIP-Seq_LS180_Human | 0.73451411 |
| 131 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.72025555 |
| 132 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.71307873 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 7.12107995 |
| 2 | MP0004084_abnormal_cardiac_muscle | 5.78405686 |
| 3 | MP0003646_muscle_fatigue | 5.63240029 |
| 4 | MP0000751_myopathy | 5.25188975 |
| 5 | MP0004215_abnormal_myocardial_fiber | 4.72050891 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.33154546 |
| 7 | MP0000749_muscle_degeneration | 3.95450449 |
| 8 | MP0005330_cardiomyopathy | 3.93075039 |
| 9 | MP0002972_abnormal_cardiac_muscle | 3.17104531 |
| 10 | MP0004087_abnormal_muscle_fiber | 3.15109280 |
| 11 | MP0003137_abnormal_impulse_conducting | 2.93097106 |
| 12 | MP0008775_abnormal_heart_ventricle | 2.89103444 |
| 13 | MP0000750_abnormal_muscle_regeneration | 2.81140532 |
| 14 | MP0005620_abnormal_muscle_contractility | 2.74007311 |
| 15 | MP0005385_cardiovascular_system_phenoty | 2.64270123 |
| 16 | MP0001544_abnormal_cardiovascular_syste | 2.64270123 |
| 17 | MP0010630_abnormal_cardiac_muscle | 2.62535901 |
| 18 | MP0002106_abnormal_muscle_physiology | 2.60200558 |
| 19 | MP0006138_congestive_heart_failure | 2.46349893 |
| 20 | MP0004130_abnormal_muscle_cell | 2.42143597 |
| 21 | MP0004484_altered_response_of | 2.36815311 |
| 22 | MP0004145_abnormal_muscle_electrophysio | 2.31830294 |
| 23 | MP0002269_muscular_atrophy | 2.31435612 |
| 24 | MP0003828_pulmonary_edema | 2.27354556 |
| 25 | MP0005369_muscle_phenotype | 2.12877774 |
| 26 | MP0004085_abnormal_heartbeat | 2.09214783 |
| 27 | MP0000747_muscle_weakness | 2.06735429 |
| 28 | MP0000759_abnormal_skeletal_muscle | 2.03541952 |
| 29 | MP0003221_abnormal_cardiomyocyte_apopto | 1.92357334 |
| 30 | MP0004510_myositis | 1.81589482 |
| 31 | MP0004233_abnormal_muscle_weight | 1.72663319 |
| 32 | MP0002127_abnormal_cardiovascular_syste | 1.62827289 |
| 33 | MP0003950_abnormal_plasma_membrane | 1.60855062 |
| 34 | MP0006036_abnormal_mitochondrial_physio | 1.57191708 |
| 35 | MP0005666_abnormal_adipose_tissue | 1.42282420 |
| 36 | MP0002332_abnormal_exercise_endurance | 1.33458458 |
| 37 | MP0003567_abnormal_fetal_cardiomyocyte | 1.31244119 |
| 38 | MP0005670_abnormal_white_adipose | 1.30184659 |
| 39 | MP0003279_aneurysm | 1.23711145 |
| 40 | MP0002234_abnormal_pharynx_morphology | 1.22221911 |
| 41 | MP0010368_abnormal_lymphatic_system | 1.18881684 |
| 42 | MP0000343_altered_response_to | 1.18501131 |
| 43 | MP0000266_abnormal_heart_morphology | 1.15013744 |
| 44 | MP0005165_increased_susceptibility_to | 1.01331078 |
| 45 | MP0004185_abnormal_adipocyte_glucose | 1.01281859 |
| 46 | MP0005375_adipose_tissue_phenotype | 1.00890414 |
| 47 | MP0002108_abnormal_muscle_morphology | 0.95477748 |
| 48 | MP0001661_extended_life_span | 0.91405383 |
| 49 | MP0006035_abnormal_mitochondrial_morpho | 0.88505988 |
| 50 | MP0005623_abnormal_meninges_morphology | 0.87583371 |
| 51 | MP0003705_abnormal_hypodermis_morpholog | 0.86612487 |
| 52 | MP0003566_abnormal_cell_adhesion | 0.85270461 |
| 53 | MP0002128_abnormal_blood_circulation | 0.83083397 |
| 54 | MP0000230_abnormal_systemic_arterial | 0.77720207 |
| 55 | MP0000733_abnormal_muscle_development | 0.77568007 |
| 56 | MP0005266_abnormal_metabolism | 0.77247832 |
| 57 | MP0000013_abnormal_adipose_tissue | 0.72233015 |
| 58 | MP0000767_abnormal_smooth_muscle | 0.69985689 |
| 59 | MP0001879_abnormal_lymphatic_vessel | 0.66513818 |
| 60 | MP0008438_abnormal_cutaneous_collagen | 0.65521631 |
| 61 | MP0000003_abnormal_adipose_tissue | 0.63963554 |
| 62 | MP0002909_abnormal_adrenal_gland | 0.63516510 |
| 63 | MP0005451_abnormal_body_composition | 0.60177972 |
| 64 | MP0004272_abnormal_basement_membrane | 0.59063000 |
| 65 | MP0005275_abnormal_skin_tensile | 0.57702968 |
| 66 | MP0003806_abnormal_nucleotide_metabolis | 0.56992699 |
| 67 | MP0002971_abnormal_brown_adipose | 0.53148290 |
| 68 | MP0004043_abnormal_pH_regulation | 0.49268068 |
| 69 | MP0002925_abnormal_cardiovascular_devel | 0.48658251 |
| 70 | MP0005187_abnormal_penis_morphology | 0.46554172 |
| 71 | MP0001299_abnormal_eye_distance/ | 0.46432388 |
| 72 | MP0003941_abnormal_skin_development | 0.46114658 |
| 73 | MP0005319_abnormal_enzyme/_coenzyme | 0.45742391 |
| 74 | MP0002078_abnormal_glucose_homeostasis | 0.42247736 |
| 75 | MP0009384_cardiac_valve_regurgitation | 0.38902572 |
| 76 | MP0001614_abnormal_blood_vessel | 0.38845164 |
| 77 | MP0004147_increased_porphyrin_level | 0.38467576 |
| 78 | MP0003984_embryonic_growth_retardation | 0.38391353 |
| 79 | MP0001784_abnormal_fluid_regulation | 0.38341823 |
| 80 | MP0008961_abnormal_basal_metabolism | 0.38238002 |
| 81 | MP0002088_abnormal_embryonic_growth/wei | 0.37104308 |
| 82 | MP0001958_emphysema | 0.32877144 |
| 83 | MP0008004_abnormal_stomach_pH | 0.31462557 |
| 84 | MP0008569_lethality_at_weaning | 0.31270331 |
| 85 | MP0003948_abnormal_gas_homeostasis | 0.30357113 |
| 86 | MP0005409_darkened_coat_color | 0.29247318 |
| 87 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.28916125 |
| 88 | MP0002638_abnormal_pupillary_reflex | 0.28788247 |
| 89 | MP0005595_abnormal_vascular_smooth | 0.27451783 |
| 90 | MP0000762_abnormal_tongue_morphology | 0.26203855 |
| 91 | MP0005535_abnormal_body_temperature | 0.26144666 |
| 92 | MP0002896_abnormal_bone_mineralization | 0.25814033 |
| 93 | MP0009840_abnormal_foam_cell | 0.24261308 |
| 94 | MP0003091_abnormal_cell_migration | 0.23983886 |
| 95 | MP0000249_abnormal_blood_vessel | 0.23815517 |
| 96 | MP0005334_abnormal_fat_pad | 0.23811914 |
| 97 | MP0005167_abnormal_blood-brain_barrier | 0.23586376 |
| 98 | MP0001727_abnormal_embryo_implantation | 0.22530841 |
| 99 | MP0008874_decreased_physiological_sensi | 0.22139801 |
| 100 | MP0009115_abnormal_fat_cell | 0.21865460 |
| 101 | MP0005503_abnormal_tendon_morphology | 0.21671656 |
| 102 | MP0003045_fibrosis | 0.21321116 |
| 103 | MP0002133_abnormal_respiratory_system | 0.20018806 |
| 104 | MP0005388_respiratory_system_phenotype | 0.20018806 |
| 105 | MP0002295_abnormal_pulmonary_circulatio | 0.19987006 |
| 106 | MP0002118_abnormal_lipid_homeostasis | 0.19834096 |
| 107 | MP0009780_abnormal_chondrocyte_physiolo | 0.19444723 |
| 108 | MP0005386_behavior/neurological_phenoty | 0.19005498 |
| 109 | MP0004924_abnormal_behavior | 0.19005498 |
| 110 | MP0002933_joint_inflammation | 0.18588059 |
| 111 | MP0002877_abnormal_melanocyte_morpholog | 0.18385506 |
| 112 | MP0009250_abnormal_appendicular_skeleto | 0.18273280 |
| 113 | MP0001672_abnormal_embryogenesis/_devel | 0.17786460 |
| 114 | MP0005380_embryogenesis_phenotype | 0.17786460 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 8.25718308 |
| 2 | Ventricular tachycardia (HP:0004756) | 6.91511756 |
| 3 | Calf muscle hypertrophy (HP:0008981) | 6.40727483 |
| 4 | Muscle fiber splitting (HP:0003555) | 6.13708273 |
| 5 | Atrial fibrillation (HP:0005110) | 6.04424058 |
| 6 | Exercise-induced myalgia (HP:0003738) | 5.93902840 |
| 7 | Exercise-induced muscle cramps (HP:0003710) | 5.91504867 |
| 8 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.89345872 |
| 9 | Primary atrial arrhythmia (HP:0001692) | 5.65467551 |
| 10 | Abnormality of the left ventricular outflow tract (HP:0011103) | 5.49054337 |
| 11 | Subaortic stenosis (HP:0001682) | 5.49054337 |
| 12 | Abnormality of the calf musculature (HP:0001430) | 5.46821078 |
| 13 | Supraventricular tachycardia (HP:0004755) | 5.46782300 |
| 14 | Lipoatrophy (HP:0100578) | 5.39774909 |
| 15 | Hyporeflexia of lower limbs (HP:0002600) | 5.38494466 |
| 16 | Supraventricular arrhythmia (HP:0005115) | 5.36682747 |
| 17 | Right ventricular cardiomyopathy (HP:0011663) | 5.15296724 |
| 18 | Syncope (HP:0001279) | 4.77994601 |
| 19 | Myoglobinuria (HP:0002913) | 4.68990775 |
| 20 | Bundle branch block (HP:0011710) | 4.51955639 |
| 21 | Dilated cardiomyopathy (HP:0001644) | 4.50736787 |
| 22 | EMG: myopathic abnormalities (HP:0003458) | 4.50437687 |
| 23 | Prolonged QT interval (HP:0001657) | 4.38494453 |
| 24 | Palpitations (HP:0001962) | 4.36325031 |
| 25 | Asymmetric septal hypertrophy (HP:0001670) | 4.25507476 |
| 26 | Increased connective tissue (HP:0009025) | 4.19471050 |
| 27 | Ventricular arrhythmia (HP:0004308) | 4.08296530 |
| 28 | Ventricular fibrillation (HP:0001663) | 3.81137059 |
| 29 | Heart block (HP:0012722) | 3.80588671 |
| 30 | Atrioventricular block (HP:0001678) | 3.77328397 |
| 31 | Difficulty running (HP:0009046) | 3.68795474 |
| 32 | Abnormal atrioventricular conduction (HP:0005150) | 3.60651538 |
| 33 | Rhabdomyolysis (HP:0003201) | 3.58788211 |
| 34 | Myotonia (HP:0002486) | 3.54713611 |
| 35 | Type 1 muscle fiber predominance (HP:0003803) | 3.42729477 |
| 36 | Muscle fiber inclusion bodies (HP:0100299) | 3.20010778 |
| 37 | Abnormal EKG (HP:0003115) | 3.15550266 |
| 38 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.13604735 |
| 39 | Difficulty climbing stairs (HP:0003551) | 3.10912941 |
| 40 | Myopathic facies (HP:0002058) | 3.02995243 |
| 41 | Left ventricular hypertrophy (HP:0001712) | 2.92221437 |
| 42 | Distal arthrogryposis (HP:0005684) | 2.92111157 |
| 43 | Round ear (HP:0100830) | 2.86097366 |
| 44 | Distal lower limb muscle weakness (HP:0009053) | 2.73460371 |
| 45 | Increased variability in muscle fiber diameter (HP:0003557) | 2.73290188 |
| 46 | Neck muscle weakness (HP:0000467) | 2.70396937 |
| 47 | Palmoplantar keratoderma (HP:0000982) | 2.69348972 |
| 48 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.60667675 |
| 49 | Hepatic necrosis (HP:0002605) | 2.60518886 |
| 50 | Limb-girdle muscle atrophy (HP:0003797) | 2.59815678 |
| 51 | Muscle stiffness (HP:0003552) | 2.54881855 |
| 52 | Areflexia of lower limbs (HP:0002522) | 2.54522274 |
| 53 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.54426346 |
| 54 | Ketoacidosis (HP:0001993) | 2.52624912 |
| 55 | Frequent falls (HP:0002359) | 2.51829480 |
| 56 | Testicular atrophy (HP:0000029) | 2.49897387 |
| 57 | Ulnar deviation of the wrist (HP:0003049) | 2.49768861 |
| 58 | Acute necrotizing encephalopathy (HP:0006965) | 2.48382858 |
| 59 | Nemaline bodies (HP:0003798) | 2.44617913 |
| 60 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.34421121 |
| 61 | Hypoglycemic coma (HP:0001325) | 2.31650914 |
| 62 | Ragged-red muscle fibers (HP:0003200) | 2.28622853 |
| 63 | Hepatocellular necrosis (HP:0001404) | 2.24947820 |
| 64 | Increased muscle lipid content (HP:0009058) | 2.23257453 |
| 65 | Abnormality of the foot musculature (HP:0001436) | 2.22935931 |
| 66 | Distal lower limb amyotrophy (HP:0008944) | 2.19518666 |
| 67 | EMG: neuropathic changes (HP:0003445) | 2.18777938 |
| 68 | Bulbar palsy (HP:0001283) | 2.18704401 |
| 69 | Conjunctival hamartoma (HP:0100780) | 2.18468549 |
| 70 | Hip contracture (HP:0003273) | 2.17994437 |
| 71 | Sudden cardiac death (HP:0001645) | 2.15655444 |
| 72 | Rimmed vacuoles (HP:0003805) | 2.15251585 |
| 73 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.14953810 |
| 74 | Acute encephalopathy (HP:0006846) | 2.12892979 |
| 75 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.07547868 |
| 76 | Dicarboxylic aciduria (HP:0003215) | 2.07547868 |
| 77 | Foot dorsiflexor weakness (HP:0009027) | 2.05251707 |
| 78 | Scapular winging (HP:0003691) | 2.05019146 |
| 79 | Mitochondrial inheritance (HP:0001427) | 2.04772130 |
| 80 | Gowers sign (HP:0003391) | 2.03825814 |
| 81 | Congestive heart failure (HP:0001635) | 2.03211472 |
| 82 | Progressive macrocephaly (HP:0004481) | 2.03050176 |
| 83 | Hypoplastic ischia (HP:0003175) | 2.02746055 |
| 84 | Muscular dystrophy (HP:0003560) | 2.02127138 |
| 85 | Generalized muscle weakness (HP:0003324) | 2.01622606 |
| 86 | Hypoplastic heart (HP:0001961) | 1.99804705 |
| 87 | Cerebral edema (HP:0002181) | 1.98379620 |
| 88 | Calcaneovalgus deformity (HP:0001848) | 1.97935798 |
| 89 | Dysmetric saccades (HP:0000641) | 1.97513567 |
| 90 | Facial diplegia (HP:0001349) | 1.96783132 |
| 91 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.96326877 |
| 92 | Spinal rigidity (HP:0003306) | 1.95438623 |
| 93 | Abnormality of the tricuspid valve (HP:0001702) | 1.94818269 |
| 94 | Increased CSF lactate (HP:0002490) | 1.93546064 |
| 95 | Increased intramyocellular lipid droplets (HP:0012240) | 1.92071699 |
| 96 | Exercise intolerance (HP:0003546) | 1.91485910 |
| 97 | Large for gestational age (HP:0001520) | 1.89747172 |
| 98 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.89711898 |
| 99 | Steppage gait (HP:0003376) | 1.86506604 |
| 100 | Waddling gait (HP:0002515) | 1.86138752 |
| 101 | Double outlet right ventricle (HP:0001719) | 1.85873251 |
| 102 | Congenital malformation of the right heart (HP:0011723) | 1.85873251 |
| 103 | Pheochromocytoma (HP:0002666) | 1.85235502 |
| 104 | Bradycardia (HP:0001662) | 1.84300240 |
| 105 | Hamartoma of the eye (HP:0010568) | 1.83064917 |
| 106 | Ketosis (HP:0001946) | 1.82214583 |
| 107 | Absent phalangeal crease (HP:0006109) | 1.81308955 |
| 108 | Progressive muscle weakness (HP:0003323) | 1.80717803 |
| 109 | Lactic acidosis (HP:0003128) | 1.80191716 |
| 110 | Respiratory failure (HP:0002878) | 1.77849150 |
| 111 | Broad metatarsal (HP:0001783) | 1.77593881 |
| 112 | Deformed tarsal bones (HP:0008119) | 1.76480803 |
| 113 | Abnormality of the ischium (HP:0003174) | 1.75178919 |
| 114 | Weak cry (HP:0001612) | 1.74205477 |
| 115 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.73951485 |
| 116 | Hypoplastic left heart (HP:0004383) | 1.73745808 |
| 117 | Proximal amyotrophy (HP:0007126) | 1.73557106 |
| 118 | Lower limb amyotrophy (HP:0007210) | 1.70898004 |
| 119 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.69911840 |
| 120 | Limited hip movement (HP:0008800) | 1.56445871 |
| 121 | Slender build (HP:0001533) | 1.55059993 |
| 122 | Increased serum pyruvate (HP:0003542) | 1.51534097 |
| 123 | Limb-girdle muscle weakness (HP:0003325) | 1.50602090 |
| 124 | Abnormality of the endocardium (HP:0004306) | 1.49673504 |
| 125 | Generalized amyotrophy (HP:0003700) | 1.49200862 |
| 126 | Abnormality of glycolysis (HP:0004366) | 1.46317123 |
| 127 | Malignant hyperthermia (HP:0002047) | 1.45950752 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 6.06656821 |
| 2 | OBSCN | 4.72646821 |
| 3 | PHKG2 | 4.03316004 |
| 4 | PHKG1 | 4.03316004 |
| 5 | LMTK2 | 3.78902300 |
| 6 | MYLK | 3.71662965 |
| 7 | DMPK | 3.28226631 |
| 8 | PDK4 | 3.25590172 |
| 9 | PDK3 | 3.25590172 |
| 10 | PKN2 | 3.14287218 |
| 11 | TRIB3 | 2.88452073 |
| 12 | MUSK | 2.49047478 |
| 13 | BCKDK | 2.30228234 |
| 14 | PIK3CA | 2.24396607 |
| 15 | NEK1 | 2.23767856 |
| 16 | TIE1 | 2.16453192 |
| 17 | PDK2 | 1.96287614 |
| 18 | STK24 | 1.94004768 |
| 19 | PINK1 | 1.86128932 |
| 20 | PAK3 | 1.38824811 |
| 21 | PRKD1 | 1.32478054 |
| 22 | GRK7 | 1.31472935 |
| 23 | LIMK1 | 1.29237166 |
| 24 | MARK1 | 1.29055608 |
| 25 | ILK | 1.26618469 |
| 26 | CAMK2D | 1.25846946 |
| 27 | MAP3K7 | 1.10883494 |
| 28 | ROCK1 | 1.09351806 |
| 29 | MAPK12 | 1.08338721 |
| 30 | MAP3K6 | 1.08141745 |
| 31 | CDC42BPA | 1.07263000 |
| 32 | MAPKAPK3 | 1.01567837 |
| 33 | RIPK1 | 0.98352076 |
| 34 | WNK4 | 0.97855338 |
| 35 | ZAK | 0.95592608 |
| 36 | STK4 | 0.94458434 |
| 37 | MAP2K3 | 0.93997283 |
| 38 | MAP3K5 | 0.93428333 |
| 39 | FLT3 | 0.86197477 |
| 40 | PRKAA1 | 0.85706626 |
| 41 | TRPM7 | 0.84836539 |
| 42 | STK38L | 0.84809618 |
| 43 | DAPK3 | 0.83055752 |
| 44 | INSRR | 0.81044536 |
| 45 | PKN1 | 0.79688533 |
| 46 | PRKAA2 | 0.78442005 |
| 47 | PDGFRA | 0.77768639 |
| 48 | MAP3K3 | 0.75600903 |
| 49 | MAPK4 | 0.74608351 |
| 50 | DDR2 | 0.72719247 |
| 51 | EPHB1 | 0.71088225 |
| 52 | EEF2K | 0.70112908 |
| 53 | TGFBR2 | 0.70040351 |
| 54 | CAMK4 | 0.67473753 |
| 55 | STK38 | 0.66858844 |
| 56 | MOS | 0.66366015 |
| 57 | ROCK2 | 0.66310931 |
| 58 | KDR | 0.63941718 |
| 59 | NME1 | 0.59899531 |
| 60 | MAP2K1 | 0.59331295 |
| 61 | RPS6KL1 | 0.58209549 |
| 62 | RPS6KC1 | 0.58209549 |
| 63 | PTK2B | 0.57516200 |
| 64 | WNK1 | 0.57095008 |
| 65 | CAMK2A | 0.55529108 |
| 66 | CAMK2B | 0.52505485 |
| 67 | KSR2 | 0.51776883 |
| 68 | ICK | 0.51708162 |
| 69 | RPS6KA6 | 0.50118711 |
| 70 | PRKACB | 0.50021803 |
| 71 | TESK1 | 0.49944975 |
| 72 | PIK3CG | 0.49846662 |
| 73 | CAMK1 | 0.46325241 |
| 74 | DYRK1B | 0.44670955 |
| 75 | MAP2K4 | 0.42049602 |
| 76 | PRKCE | 0.41972657 |
| 77 | AKT2 | 0.41624788 |
| 78 | PTK6 | 0.39326801 |
| 79 | SIK1 | 0.38220128 |
| 80 | PRKACA | 0.38186773 |
| 81 | PRKACG | 0.37120865 |
| 82 | NEK9 | 0.37060524 |
| 83 | PDPK1 | 0.36865546 |
| 84 | CAMK2G | 0.33636727 |
| 85 | EPHB2 | 0.30303954 |
| 86 | PRKCH | 0.29417708 |
| 87 | PRKD3 | 0.28767066 |
| 88 | PDK1 | 0.28336197 |
| 89 | FER | 0.27979429 |
| 90 | STK39 | 0.27137675 |
| 91 | UHMK1 | 0.26026194 |
| 92 | PRPF4B | 0.25295731 |
| 93 | LATS2 | 0.24759549 |
| 94 | MTOR | 0.24410658 |
| 95 | PAK2 | 0.24394336 |
| 96 | RPS6KA1 | 0.23999778 |
| 97 | LATS1 | 0.22826798 |
| 98 | MAPK10 | 0.22556054 |
| 99 | PRKG2 | 0.21382780 |
| 100 | TAOK1 | 0.20776826 |
| 101 | RET | 0.19987117 |
| 102 | NLK | 0.19539974 |
| 103 | ZAP70 | 0.19510434 |
| 104 | MARK2 | 0.19390811 |
| 105 | PRKG1 | 0.19337467 |
| 106 | SGK3 | 0.18319553 |
| 107 | EPHA3 | 0.18281555 |
| 108 | JAK1 | 0.17827202 |
| 109 | LRRK2 | 0.17647691 |
| 110 | ERBB3 | 0.16708899 |
| 111 | RPS6KA2 | 0.16486961 |
| 112 | SGK1 | 0.15352084 |
| 113 | MAPK11 | 0.15248760 |
| 114 | MAPK7 | 0.15117532 |
| 115 | FGFR4 | 0.15070690 |
| 116 | ARAF | 0.14909259 |
| 117 | SGK2 | 0.14612354 |
| 118 | RPS6KA3 | 0.14204554 |
| 119 | PTK2 | 0.13999319 |
| 120 | RPS6KB2 | 0.13458680 |
| 121 | MAP3K10 | 0.13178000 |
| 122 | MAP3K1 | 0.13053876 |
| 123 | MAPKAPK2 | 0.11327008 |
| 124 | MAP2K6 | 0.10501120 |
| 125 | NME2 | 0.10327763 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.81423540 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.42897900 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.33229818 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 4.05634283 |
| 5 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.98378828 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.42935927 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.06603947 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 2.96442342 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.84872729 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.77313151 |
| 11 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.68363830 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.40249526 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.20035531 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.11647822 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.08210189 |
| 16 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.02140061 |
| 17 | Viral myocarditis_Homo sapiens_hsa05416 | 1.93814488 |
| 18 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.86953286 |
| 19 | Huntingtons disease_Homo sapiens_hsa05016 | 1.80177314 |
| 20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.71291968 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.37082679 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.29578229 |
| 23 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.21451780 |
| 24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.16186422 |
| 25 | Insulin resistance_Homo sapiens_hsa04931 | 1.13062934 |
| 26 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.10517388 |
| 27 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.08410794 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.08300236 |
| 29 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.06187417 |
| 30 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.05503444 |
| 31 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.02249048 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.00720918 |
| 33 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.94998639 |
| 34 | Focal adhesion_Homo sapiens_hsa04510 | 0.83774129 |
| 35 | Lysine degradation_Homo sapiens_hsa00310 | 0.80918817 |
| 36 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.78272863 |
| 37 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.77579549 |
| 38 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.77523234 |
| 39 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.76770036 |
| 40 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.75697581 |
| 41 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.74803320 |
| 42 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.71719463 |
| 43 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.66620681 |
| 44 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.66523907 |
| 45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.66105200 |
| 46 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.65926568 |
| 47 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.65033682 |
| 48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.64735888 |
| 49 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.64647028 |
| 50 | Tight junction_Homo sapiens_hsa04530 | 0.64574925 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.63242622 |
| 52 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.59215443 |
| 53 | Galactose metabolism_Homo sapiens_hsa00052 | 0.57528590 |
| 54 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.56642543 |
| 55 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51301720 |
| 56 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.51074673 |
| 57 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.50321544 |
| 58 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50283782 |
| 59 | Renin secretion_Homo sapiens_hsa04924 | 0.46247636 |
| 60 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.43700162 |
| 61 | Adherens junction_Homo sapiens_hsa04520 | 0.42932094 |
| 62 | Amoebiasis_Homo sapiens_hsa05146 | 0.42513491 |
| 63 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.42485618 |
| 64 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.42049942 |
| 65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.41483954 |
| 66 | Peroxisome_Homo sapiens_hsa04146 | 0.38798235 |
| 67 | Insulin secretion_Homo sapiens_hsa04911 | 0.38055145 |
| 68 | Long-term potentiation_Homo sapiens_hsa04720 | 0.37968708 |
| 69 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.37532367 |
| 70 | Melanogenesis_Homo sapiens_hsa04916 | 0.36054320 |
| 71 | Salivary secretion_Homo sapiens_hsa04970 | 0.35531592 |
| 72 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.33640165 |
| 73 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.29758083 |
| 74 | Prion diseases_Homo sapiens_hsa05020 | 0.29690449 |
| 75 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.28642418 |
| 76 | Circadian rhythm_Homo sapiens_hsa04710 | 0.27965342 |
| 77 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.27219932 |
| 78 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.26284245 |
| 79 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.26036615 |
| 80 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.24844920 |
| 81 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.24504958 |
| 82 | Sulfur relay system_Homo sapiens_hsa04122 | 0.24488043 |
| 83 | GABAergic synapse_Homo sapiens_hsa04727 | 0.24272312 |
| 84 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.23910376 |
| 85 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.23739455 |
| 86 | Circadian entrainment_Homo sapiens_hsa04713 | 0.23354342 |
| 87 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.22111655 |
| 88 | Platelet activation_Homo sapiens_hsa04611 | 0.19733441 |
| 89 | Morphine addiction_Homo sapiens_hsa05032 | 0.18955291 |
| 90 | Metabolic pathways_Homo sapiens_hsa01100 | 0.18348478 |
| 91 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.18261932 |
| 92 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.17384959 |
| 93 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.15924343 |
| 94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.15912554 |
| 95 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.15686324 |
| 96 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.15479214 |
| 97 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.15404216 |
| 98 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.15241032 |
| 99 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.14327069 |
| 100 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13717884 |
| 101 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.13496039 |
| 102 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.12490082 |
| 103 | Gap junction_Homo sapiens_hsa04540 | 0.11608585 |
| 104 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.10814622 |
| 105 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.10389112 |
| 106 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.09670115 |
| 107 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.09061065 |
| 108 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.08532925 |
| 109 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.07397586 |
| 110 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.06067683 |
| 111 | Bile secretion_Homo sapiens_hsa04976 | 0.05795838 |
| 112 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.05246414 |
| 113 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.03848416 |
| 114 | Taste transduction_Homo sapiens_hsa04742 | 0.02737189 |
| 115 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.02428986 |
| 116 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.01236630 |

